Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Hiroshi Fukushima, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison. Front Oncol. 2024; 14 1527540. ( PubMed, DOI )

Wei Chen. Prognostic nomograms incorporating preoperative CRP level for predicting survival outcomes in patients with nonmetastatic clear cell renal cell carcinoma: INMARC study. AUA annual meeting 2024 2024.05.05

Wei Chen. Development and validation of prognostic nomograms and integrated software incorporating preoperative CRP level for predicting survival outcomes in patients with nonmetastatic clear cell renal cell carcinoma: INMARC study. 39th Annual congress of EAU 2024.04.06

Chen Wei. Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: a Japanese nationwide study. the 110th Annual Meeting of the Japanese Urological Association 2023.04.22

陳　煒. 非転移性淡明細胞型腎細胞癌の予後予測における術前 CRP 至適カットオフ値の人種差: 国際多施設共同研究". 日本泌尿器腫瘍学会第10回学術集会 2024.10.26

陳 煒. "術前CRP値に基づく非転移性淡明細胞型腎細胞癌の予後予測ノモグラムの作成と検 証:国際多施設共同研究". 日本泌尿器腫瘍学会第9回学術集会 2023.10.22